Application 204059
- Type
- ANDA
- Sponsor
- BAYSHORE PHARMS LLC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | KETOTIFEN FUMARATE | KETOTIFEN FUMARATE | SOLUTION/DROPS;OPHTHALMIC | EQ 0.025% BASE | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A204059-001 | KETOTIFEN FUMARATE | KETOTIFEN FUMARATE | EQ 0.025% BASE | SOLUTION/DROPS / OPHTHALMIC | 2020-06-01 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A204059-001 | KETOTIFEN FUMARATE | EQ 0.025% BASE | SOLUTION/DROPS / OPHTHALMIC | 2020-06-01 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ketotifen Fumarate | KETOTIFEN FUMARATE | Preferred Pharmaceuticals Inc. | 5196ec5b-42d9-40db-a77a-c00360b8cee6 | 2026-05-15 | Warnings | 204059 ANDA204059 |
| KETOTIFEN FUMARATE | KETOTIFEN FUMARATE | Unichem Pharmaceuticals (USA), Inc. | 0fe119ad-cb44-4e90-a096-0ed0ba63dc31 | 2025-11-24 | 204059 ANDA204059 76385-106 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 76385-106 | Ketotifen Fumarate | Ketotifen Fumarate | Bayshore Pharmaceuticals, LLC | ANDA | Current |